Ainos Inc.报告不寻常的股票交易,并呼吁NASDAQ和SEC进行调查。 Ainos Inc. reports unusual stock trading and calls for NASDAQ and SEC investigations.

Ainos Inc.是一家以AI驱动的护理点检测和低剂量干涉治疗为重点的保健公司,它就其库存不寻常的交易活动,特别是大宗销售订单,向NASDAQ和SEC提出投诉。 Ainos Inc., a healthcare firm focused on AI-driven point-of-care testing and low-dose interferon treatments, has filed complaints with NASDAQ and the SEC regarding unusual trading activities in its stock, particularly large-volume sell orders. 公司怀疑这些交易可能违反条例,并敦促进行彻底调查,以确保市场公平并保护股东。 The company suspects these trades may violate regulations and is urging a thorough investigation to ensure market fairness and protect shareholders. 阿伊诺斯致力于保持透明度,并在这些关切中保持投资者的信心。 Ainos is committed to transparency and maintaining investor confidence amid these concerns.